<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="decrease">
            <roleset id="decrease.02" name="" wordnet="1">
                <roles>
                    <role n="0" descr="theme&#x0A;" />
                    <role n="2" descr="amount decreased &#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="location&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>Also, is the CD3 statement shown to be decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="1">
                    <text>By contrast, GP is able to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>By contrast, GP is predicted that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>Concomitantly, acetycoline levels are able to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Concomitantly, acetycoline levels can decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Concomitantly, acetycoline levels can decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Concomitantly, acetycoline levels could decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Concomitantly, acetycoline levels decreased by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Concomitantly, acetycoline levels decreased in 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Concomitantly, acetycoline levels decreases by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Concomitantly, acetycoline levels have decreased by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Concomitantly, acetycoline levels may have decreased by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>Concomitantly, acetycoline levels may have decreased in 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Concomitantly, acetycoline levels was able to decrease in 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Concomitantly, acetycoline levels was shown to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Concomitantly, acetycoline levels were able to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Concomitantly, acetycoline levels will decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>Concomitantly, acetycoline levels will have decreased in 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>Concomitantly, acetycoline levels would decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>Concomitantly, acetylcholine levels decreased by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>Concomitantly, acetylcholine levels decreases by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>Concomitantly, acetylcholine levels is able to decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>Concomitantly, acetylcholine levels may have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>Concomitantly, acetylcholine levels will decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>Concomitantly, acetylcholine levels would decrease by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>Concomitantly, acetylcholine levels would have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>Concomitantly, it was predicted that acetycoline levels will decrease by 37.8% in lead animals treated as lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>Concomitantly, it was predicted that acetycoline levels would decrease in 37.8% in lead animals treated with lead compared to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>Concomitantly, it was shown that acetycoline levels decreases by 37.8% in lead animals treated with lead decrease to controls.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>In addition, CD3 expression could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>In addition, CD3 expression has the ability to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="33">
                    <text>In addition, CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="34">
                    <text>In addition, CD3 expression? is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>In addition, CD3 expression? would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>In addition, CD3? expression can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>In addition, CD3? expression could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>In addition, CD3? expression could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>In addition, CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>In addition, CD3? expression has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>In addition, CD3? expression has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>In addition, CD3? expression is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>In addition, CD3? expression was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>In addition, CD3? expression will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>In addition, CD3? expression will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>In addition, CD3? expression would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>In addition, it has been decrease that CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>In addition, it is decrease that CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>In addition, the CD3 expression has the ability to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent (Fig.2B) way.</text>
                </example>
                <example src="EGRAM" no="54">
                    <text>In addition, the CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent (Fig.2B) way.</text>
                </example>
                <example src="EGRAM" no="55">
                    <text>In addition, the CD3? expression decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>In addition, the CD3? expression is decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                </example>
                <example src="EGRAM" no="57">
                    <text>In addition, the expression CD3? was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>In addition, the expression of CD3? can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>In addition, the expression of CD3? expression decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>In addition, the expression of CD3? is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>In addition, the expression of CD3? will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>In contrast, G may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>In contrast, GP is able to decrease only only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>In contrast, GP is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>In contrast, GP may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>In contrast, GP may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>In contrast, GP was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>In contrast, GP was demonstrated by only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>In contrast, GP will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>In contrast, PG could decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>In contrast, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>In contrast, PG is found to decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) A1 (in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>In contrast, PG may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>In contrast, PG may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>In contrast, PG showed that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>In contrast, PG showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>In contrast, PG was found to decrease 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) A1 (in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>In contrast, PG was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>In contrast, PG will decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>In contrast, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>Instead, GP decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>Instead, GP may have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>Instead, GP was decreased by decreased only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>Instead, GP would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="85">
                    <text>Instead, GP would have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="86">
                    <text>Instead, PG can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="87">
                    <text>Instead, PG can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="88">
                    <text>Instead, PG is found to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) A1 (in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="89">
                    <text>Instead, PG was found to decrease 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) A1 (in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="EGRAM" no="90">
                    <text>Instead, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>By contrast, G is able to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>By contrast, G is predicted that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>By contrast, GP is able to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>By contrast, GP is able to decrease only by in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>By contrast, GP is able to decrease only by in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>By contrast, GP is predicted that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>By contrast, GP is predicted that only decreased by in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>By contrast, GP is predicted that only decreased by in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>By contrast, PG is able to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>By contrast, PG is able to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>By contrast, PG is able to decrease only by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>By contrast, PG is able to decrease only by in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>By contrast, PG is predicted that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>By contrast, PG is predicted that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>By contrast, PG is predicted that only decreased by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>By contrast, PG is predicted that only decreased by in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>In addition, CD3 expression can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>In addition, CD3 expression can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>In addition, CD3 expression can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>In addition, CD3 expression could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>In addition, CD3 expression could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>In addition, CD3 expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>In addition, CD3 expression has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>In addition, CD3 expression has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>In addition, CD3 expression is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>In addition, CD3 expression is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>In addition, CD3 expression may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>In addition, CD3 expression may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>In addition, CD3 expression was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>In addition, CD3 expression will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>In addition, CD3 expression will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>In addition, CD3 expression would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>In addition, CD3 expression would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>In addition, CD3 expression? can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>In addition, CD3 expression? can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>In addition, CD3 expression? can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>In addition, CD3 expression? could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>In addition, CD3 expression? could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>In addition, CD3 expression? could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>In addition, CD3 expression? decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>In addition, CD3 expression? has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>In addition, CD3 expression? has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>In addition, CD3 expression? is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>In addition, CD3 expression? may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>In addition, CD3 expression? may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>In addition, CD3 expression? was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>In addition, CD3 expression? will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>In addition, CD3 expression? will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>In addition, CD3 expression? would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>In addition, CD3? can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>In addition, CD3? can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>In addition, CD3? can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>In addition, CD3? could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>In addition, CD3? could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>In addition, CD3? could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>In addition, CD3? decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>In addition, CD3? expression could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>In addition, CD3? expression is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>In addition, CD3? expression would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>In addition, CD3? has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>In addition, CD3? has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>In addition, CD3? is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>In addition, CD3? is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>In addition, CD3? may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>In addition, CD3? may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>In addition, CD3? was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>In addition, CD3? will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>In addition, CD3? will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>In addition, CD3? would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>In addition, CD3? would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>In addition, the CD3 expression decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>In addition, the CD3 expression? decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>In addition, the CD3? decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>In addition, the expression CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>In addition, the expression CD3 expression? was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>In addition, the expression CD3? expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>In addition, the expression of CD3 expression can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>In addition, the expression of CD3 expression decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>In addition, the expression of CD3 expression is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>In addition, the expression of CD3 expression will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">CD3 expression</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>In addition, the expression of CD3 expression? can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>In addition, the expression of CD3 expression? decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>In addition, the expression of CD3 expression? is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>In addition, the expression of CD3 expression? will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">CD3 expression?</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>In addition, the expression of CD3? decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3?</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>In addition, the expression of CD3? expression can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>In addition, the expression of CD3? expression is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>In addition, the expression of CD3? expression will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">CD3? expression</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>In contrast, G could decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>In contrast, G decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>In contrast, G is able to decrease only only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>In contrast, G is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>In contrast, G may decrease only only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>In contrast, G may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>In contrast, G showed that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>In contrast, G showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>In contrast, G was decreased by the reduction of only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>In contrast, G was demonstrated by only decreased by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>In contrast, G was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>In contrast, G will decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>In contrast, G will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>In contrast, G would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>In contrast, GP could decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>In contrast, GP could decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>In contrast, GP could decrease only only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>In contrast, GP could decrease only only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>In contrast, GP decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>In contrast, GP decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>In contrast, GP decreased a reduction in only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>In contrast, GP decreased a reduction in only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>In contrast, GP is able to decrease only only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>In contrast, GP is able to decrease only only by in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>In contrast, GP is able to decrease only only by in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>In contrast, GP is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>In contrast, GP is predicted that only decreased in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>In contrast, GP is predicted that only decreased in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>In contrast, GP may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>In contrast, GP may decrease only only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>In contrast, GP may decrease only only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>In contrast, GP may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>In contrast, GP may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>In contrast, GP may have decreased in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>In contrast, GP may have decreased in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>In contrast, GP showed that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>In contrast, GP showed that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>In contrast, GP showed that only decreased by in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>In contrast, GP showed that only decreased by in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>In contrast, GP showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>In contrast, GP showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>In contrast, GP showed that only decreased in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>In contrast, GP showed that only decreased in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>In contrast, GP was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>In contrast, GP was decreased by the reduction of only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>In contrast, GP was demonstrated by only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>In contrast, GP was demonstrated by only decreased by in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>In contrast, GP was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>In contrast, GP was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>In contrast, GP was predicted for only decreased in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>In contrast, GP was predicted for only decreased in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>In contrast, GP will decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>In contrast, GP will decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>In contrast, GP will decrease only only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>In contrast, GP will decrease only only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>In contrast, GP will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>In contrast, GP will only decrease only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>In contrast, GP will only decrease only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>In contrast, GP would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>In contrast, GP would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>In contrast, GP would only decrease only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>In contrast, GP would only decrease only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>In contrast, PG could decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>In contrast, PG could decrease only only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>In contrast, PG could decrease only only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>In contrast, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>In contrast, PG decreased a reduction in only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>In contrast, PG decreased a reduction in only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>In contrast, PG is able to decrease only only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>In contrast, PG is able to decrease only only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>In contrast, PG is able to decrease only only by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>In contrast, PG is able to decrease only only by in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>In contrast, PG is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>In contrast, PG is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>In contrast, PG is predicted that only decreased in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>In contrast, PG is predicted that only decreased in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>In contrast, PG may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>In contrast, PG may decrease only only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>In contrast, PG may decrease only only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>In contrast, PG may have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>In contrast, PG may have decreased in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>In contrast, PG may have decreased in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>In contrast, PG showed that only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>In contrast, PG showed that only decreased by in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>In contrast, PG showed that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>In contrast, PG showed that only decreased in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>In contrast, PG was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>In contrast, PG was decreased by the reduction of only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>In contrast, PG was decreased by the reduction of only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>In contrast, PG was decreased by the reduction of only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>In contrast, PG was demonstrated by only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>In contrast, PG was demonstrated by only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>In contrast, PG was demonstrated by only decreased by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>In contrast, PG was demonstrated by only decreased by in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>In contrast, PG was predicted for only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>In contrast, PG was predicted for only decreased in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>In contrast, PG was predicted for only decreased in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>In contrast, PG will decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>In contrast, PG will decrease only only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>In contrast, PG will decrease only only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>In contrast, PG will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>In contrast, PG will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>In contrast, PG will only decrease only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>In contrast, PG will only decrease only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>In contrast, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>In contrast, PG would only decrease only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>In contrast, PG would only decrease only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>Instead, G can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>Instead, G can decrease only only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>Instead, G decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>Instead, G may have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>Instead, G would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>Instead, G would have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>Instead, G would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">G</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>Instead, GP can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>Instead, GP can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>Instead, GP can decrease only only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>Instead, GP can decrease only only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>Instead, GP decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>Instead, GP decreased a reduction in only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>Instead, GP decreased a reduction in only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>Instead, GP may have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>Instead, GP may have decreased by in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>Instead, GP may have decreased by in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>Instead, GP would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>Instead, GP would have decreased by in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>Instead, GP would have decreased by in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>Instead, GP would have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>Instead, GP would have decreased in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>Instead, GP would have decreased in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>Instead, GP would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>Instead, GP would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>Instead, GP would only decrease only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>Instead, GP would only decrease only in in those with little or no increase in plasma citrulline concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>Instead, PG can decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>Instead, PG can decrease only only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>Instead, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>Instead, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>Instead, PG decreased a reduction in only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>Instead, PG decreased a reduction in only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>Instead, PG may have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>Instead, PG may have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>Instead, PG may have decreased by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>Instead, PG may have decreased by in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>Instead, PG would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>Instead, PG would have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>Instead, PG would have decreased by in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>Instead, PG would have decreased by in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>Instead, PG would have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>Instead, PG would have decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>Instead, PG would have decreased in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>Instead, PG would have decreased in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>Instead, PG would only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>Instead, PG would only decrease only in in people with little or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>Instead, PG would only decrease only in in people with little or no increase in plasma cytrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">PG</arg>
                    <arg n="1">12.4% +/-3.9%</arg>
                    <arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>By contrast, acetycoline levels is able to decrease only by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>By contrast, acetycoline levels is able to decrease only by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>By contrast, acetycoline levels is able to decrease only by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>By contrast, acetycoline levels is predicted that only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>By contrast, acetycoline levels is predicted that only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>By contrast, acetycoline levels is predicted that only decreased by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>By contrast, acetylcholine levels is able to decrease only by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>By contrast, acetylcholine levels is able to decrease only by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>By contrast, acetylcholine levels is predicted that only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>By contrast, acetylcholine levels is predicted that only decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>In addition, GP can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>In addition, GP can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>In addition, GP can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>In addition, GP could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>In addition, GP could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>In addition, GP could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>In addition, GP decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>In addition, GP has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>In addition, GP has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>In addition, GP is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>In addition, GP is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>In addition, GP may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>In addition, GP may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>In addition, GP was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>In addition, GP will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>In addition, GP will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>In addition, GP would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>In addition, GP would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>In addition, acetycoline levels can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>In addition, acetycoline levels can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>In addition, acetycoline levels can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>In addition, acetycoline levels could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>In addition, acetycoline levels could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>In addition, acetycoline levels could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>In addition, acetycoline levels decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>In addition, acetycoline levels has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>In addition, acetycoline levels has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>In addition, acetycoline levels is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>In addition, acetycoline levels is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>In addition, acetycoline levels may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>In addition, acetycoline levels may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>In addition, acetycoline levels was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>In addition, acetycoline levels will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>In addition, acetycoline levels will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>In addition, acetycoline levels would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>In addition, acetycoline levels would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>In addition, acetylcholine levels can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>In addition, acetylcholine levels can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>In addition, acetylcholine levels can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>In addition, acetylcholine levels could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>In addition, acetylcholine levels could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>In addition, acetylcholine levels could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>In addition, acetylcholine levels decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>In addition, acetylcholine levels has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>In addition, acetylcholine levels has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>In addition, acetylcholine levels is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>In addition, acetylcholine levels is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>In addition, acetylcholine levels may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>In addition, acetylcholine levels may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>In addition, acetylcholine levels was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>In addition, acetylcholine levels will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>In addition, acetylcholine levels will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>In addition, acetylcholine levels would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>In addition, acetylcholine levels would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>In addition, the GP decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>In addition, the acetycoline levels decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>In addition, the acetylcholine levels decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>In addition, the expression GP was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>In addition, the expression acetycoline levels was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>In addition, the expression acetylcholine levels was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>In addition, the expression of GP can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>In addition, the expression of GP decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>In addition, the expression of GP is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>In addition, the expression of GP will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">GP</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>In addition, the expression of acetycoline levels can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>In addition, the expression of acetycoline levels decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>In addition, the expression of acetycoline levels is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>In addition, the expression of acetycoline levels will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">acetycoline levels</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>In addition, the expression of acetylcholine levels can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>In addition, the expression of acetylcholine levels decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>In addition, the expression of acetylcholine levels is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>In addition, the expression of acetylcholine levels will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
                    <arg n="0">acetylcholine levels</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>In contrast, GP is able to decrease only only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>In contrast, GP is predicted that only decreased in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>In contrast, GP may decrease only only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>In contrast, GP was decreased by the reduction of only in in people with small or no increase in plasma citrullin concentration (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 12.4% +/-3.9%.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>In contrast, GP will only decrease only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>In contrast, acetycoline levels could decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>In contrast, acetycoline levels could decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>In contrast, acetycoline levels could decrease only only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>In contrast, acetycoline levels decreased a reduction in only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>In contrast, acetycoline levels decreased a reduction in only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>In contrast, acetycoline levels decreased a reduction in only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>In contrast, acetycoline levels is able to decrease only only by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>In contrast, acetycoline levels is able to decrease only only by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>In contrast, acetycoline levels is able to decrease only only by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>In contrast, acetycoline levels is predicted that only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>In contrast, acetycoline levels is predicted that only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>In contrast, acetycoline levels is predicted that only decreased in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>In contrast, acetycoline levels may decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>In contrast, acetycoline levels may decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>In contrast, acetycoline levels may decrease only only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>In contrast, acetycoline levels may decrease only only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>In contrast, acetycoline levels may have decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>In contrast, acetycoline levels may have decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>In contrast, acetycoline levels may have decreased in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>In contrast, acetycoline levels showed that only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>In contrast, acetycoline levels showed that only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>In contrast, acetycoline levels showed that only decreased by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>In contrast, acetycoline levels showed that only decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>In contrast, acetycoline levels showed that only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>In contrast, acetycoline levels showed that only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>In contrast, acetycoline levels showed that only decreased in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>In contrast, acetycoline levels showed that only decreased in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>In contrast, acetycoline levels was decreased by the reduction of only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>In contrast, acetycoline levels was decreased by the reduction of only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>In contrast, acetycoline levels was decreased by the reduction of only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>In contrast, acetycoline levels was demonstrated by only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>In contrast, acetycoline levels was demonstrated by only decreased by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>In contrast, acetycoline levels was demonstrated by only decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>In contrast, acetycoline levels was predicted for only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>In contrast, acetycoline levels was predicted for only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>In contrast, acetycoline levels was predicted for only decreased in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>In contrast, acetycoline levels will decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>In contrast, acetycoline levels will decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>In contrast, acetycoline levels will decrease only only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>In contrast, acetycoline levels will only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>In contrast, acetycoline levels will only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>In contrast, acetycoline levels will only decrease only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>In contrast, acetycoline levels would only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>In contrast, acetycoline levels would only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>In contrast, acetycoline levels would only decrease only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>In contrast, acetylcholine levels could decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>In contrast, acetylcholine levels could decrease only only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>In contrast, acetylcholine levels decreased a reduction in only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>In contrast, acetylcholine levels decreased a reduction in only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>In contrast, acetylcholine levels is able to decrease only only by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>In contrast, acetylcholine levels is able to decrease only only by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>In contrast, acetylcholine levels is predicted that only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>In contrast, acetylcholine levels is predicted that only decreased in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>In contrast, acetylcholine levels may decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>In contrast, acetylcholine levels may decrease only only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>In contrast, acetylcholine levels may have decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>In contrast, acetylcholine levels may have decreased in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>In contrast, acetylcholine levels showed that only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>In contrast, acetylcholine levels showed that only decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>In contrast, acetylcholine levels showed that only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>In contrast, acetylcholine levels showed that only decreased in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>In contrast, acetylcholine levels was decreased by the reduction of only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>In contrast, acetylcholine levels was decreased by the reduction of only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>In contrast, acetylcholine levels was demonstrated by only decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>In contrast, acetylcholine levels was demonstrated by only decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>In contrast, acetylcholine levels was predicted for only decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>In contrast, acetylcholine levels was predicted for only decreased in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>In contrast, acetylcholine levels will decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>In contrast, acetylcholine levels will decrease only only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>In contrast, acetylcholine levels will only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>In contrast, acetylcholine levels will only decrease only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>In contrast, acetylcholine levels would only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>In contrast, acetylcholine levels would only decrease only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>Instead, GP decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
                    <arg n="2">12.4% +/-3.9%</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>Instead, acetycoline levels can decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>Instead, acetycoline levels can decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>Instead, acetycoline levels can decrease only only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>Instead, acetycoline levels can decrease only only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>Instead, acetycoline levels decreased a reduction in only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>Instead, acetycoline levels decreased a reduction in only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>Instead, acetycoline levels decreased a reduction in only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>Instead, acetycoline levels may have decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>Instead, acetycoline levels may have decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>Instead, acetycoline levels may have decreased by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>Instead, acetycoline levels would have decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>Instead, acetycoline levels would have decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>Instead, acetycoline levels would have decreased by lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>Instead, acetycoline levels would have decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>Instead, acetycoline levels would have decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>Instead, acetycoline levels would have decreased in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>Instead, acetycoline levels would only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated as lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated as lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Instead, acetycoline levels would only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Instead, acetycoline levels would only decrease only in lead animals treated as lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetycoline levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated as lead</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Instead, acetylcholine levels can decrease only only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Instead, acetylcholine levels can decrease only only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Instead, acetylcholine levels decreased a reduction in only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Instead, acetylcholine levels decreased a reduction in only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Instead, acetylcholine levels may have decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Instead, acetylcholine levels may have decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Instead, acetylcholine levels would have decreased by 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Instead, acetylcholine levels would have decreased by lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>Instead, acetylcholine levels would have decreased in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>Instead, acetylcholine levels would have decreased in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>Instead, acetylcholine levels would only decrease only in 37.8% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) lead animals treated with lead.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">lead animals treated with lead</arg>
                    <arg n="2">37.8%</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>Instead, acetylcholine levels would only decrease only in lead animals treated with lead (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) 37.8%.</text>
                    <arg n="0">acetylcholine levels</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">lead animals treated with lead</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
